Keywords: cialis, offers, 24-hour, activity, impotence, new, clinical
Cialis offers 24-hour activity in impotence
Article | 02 May 2001
New clinical trial results on Eli Lilly and ICOS' phosphodiesteraseinhibitor Cialis (IC-351), a potential rival to Pfizer's blockbuster Viagra (sildenafil) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
